Your browser is old and is not supported. Upgrade for better security.

BioClonetics Immunotherapeutics

Designing the first cure for HIV through the use of monoclonal antibodies

Highlights

1
We have created a cell line that produces an anti-HIV antibody called Clone 3.
2
We have demonstrated that Clone 3 neutralizes all clades and groups of HIV isolates.
3
We have identified that Clone 3 targets HIV at an immutable site on the HIV virus.
4
We expect to complete animal trials within 18 to 24 months.
5
We are working with several world-class laboratories who will assist us in conducting the next steps of our plan.
6
1.2 million estimated people die from HIV each year.
7
2 million estimated people are infected with HIV each year.

Our Team


Downloads

Overview